Jiangxi Rimag Group's (HKG:2522) subsidiary Rimag Health Management agreed to purchase registered capital of 3.3 million yuan representing 18% equity interest in Shanghai Ronggongshe Fanghou Technology from Gongqingcheng Fanghou No.1 Investment Partnership for 17.3 million yuan, a Friday Hong Kong bourse filing said.
The group will fund the acquisition with its internal financial resources.
The medical imaging solution services company plans to use the innovative financial service solutions of the target company together with its imaging solutions to expand its reach and coverage in the industry chain it belongs to.
Price (HKD): $2210.13, Change: $+13, Percent Change: +0.61%
Comments